Insmed Days Sales Outstanding from 2010 to 2024

INSM Stock  USD 24.16  0.37  1.51%   
Insmed Days Sales Outstanding yearly trend continues to be very stable with very little volatility. Days Sales Outstanding is likely to drop to 46.80. During the period from 2010 to 2024, Insmed Days Sales Outstanding quarterly data regression pattern had sample variance of 1.2 M and median of  204.67. View All Fundamentals
 
Days Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
49.25816165
Current Value
46.8
Quarterly Volatility
1.1 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Insmed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insmed main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.1 M, Interest Expense of 80.1 M or Total Revenue of 320.5 M, as well as many exotic indicators such as Price To Sales Ratio of 13.55, Dividend Yield of 0.0 or Days Sales Outstanding of 46.8. Insmed financial statements analysis is a perfect complement when working with Insmed Valuation or Volatility modules.
  
This module can also supplement Insmed's financial leverage analysis and stock options assessment as well as various Insmed Technical models . Check out the analysis of Insmed Correlation against competitors.

Latest Insmed's Days Sales Outstanding Growth Pattern

Below is the plot of the Days Sales Outstanding of Insmed Inc over the last few years. It is Insmed's Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Insmed's overall financial position and show how it may be relating to other accounts over time.
Days Sales Outstanding10 Years Trend
Slightly volatile
   Days Sales Outstanding   
       Timeline  

Insmed Days Sales Outstanding Regression Statistics

Arithmetic Mean407.51
Geometric Mean127.25
Coefficient Of Variation267.77
Mean Deviation524.57
Median204.67
Standard Deviation1,091
Sample Variance1.2M
Range4.3K
R-Value(0.47)
Mean Square Error994,136
R-Squared0.22
Significance0.07
Slope(115.67)
Total Sum of Squares16.7M

Insmed Days Sales Outstanding History

2024 46.8
2023 49.26
2022 44.2
2021 47.16
2020 36.77
2019 51.44

About Insmed Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Insmed income statement, its balance sheet, and the statement of cash flows. Insmed investors use historical funamental indicators, such as Insmed's Days Sales Outstanding, to determine how well the company is positioned to perform in the future. Although Insmed investors may use each financial statement separately, they are all related. The changes in Insmed's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Insmed's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Insmed Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Insmed. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Sales Outstanding 49.26  46.80 

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Insmed Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Check out the analysis of Insmed Correlation against competitors.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Complementary Tools for Insmed Stock analysis

When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.15)
Revenue Per Share
2.199
Quarterly Revenue Growth
0.158
Return On Assets
(0.32)
Return On Equity
(14.53)
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.